The FDA said it bypassed input from the agency’s independent advisers because it didn’t see any “concerns or controversial issues.” Moderna is running at least 11 clinical trials for its new mRNA RSV drug on other demographic groups, including young children, adolescents and healthy adults.

The U.S. Food and Drug Administration (FDA) last week approved Moderna’s mRNA respiratory syncytial virus (RSV) vaccine for adults age 60 and older.


They are going to keep breaking the rules until these become the new rules OR someone tells them to stop. A lawless society!